FDA Clearance Tracker · K260265
MAGNETOM Flow.Ace; MAGNETOM Flow.Plus
Last checked: Nov 19, 2026Latest source record: Feb 23, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 23, 2026
Substantially Equivalent
Time to decision
26 days
Received Jan 28, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K260265
- Device name
- MAGNETOM Flow.Ace; MAGNETOM Flow.Plus
- Applicant location
- Shenzhen, CN
- Received
- Jan 28, 2026
- Decided
- Feb 23, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1000
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LNH. The earliest in FDA's data is P830053-S001, decided Aug 14, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260265
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Siemens Shenzhen Magnetic Resonance , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260758 · Decided Sep 1, 2026 · 176 days after receipt
Device type: System, Nuclear Magnetic Resonance Imaging (LNH) · Radiology & Imaging
K251822 · Decided Nov 20, 2025 · 160 days after receipt
Device type: System, Nuclear Magnetic Resonance Imaging (LNH) · Radiology & Imaging
K250436 · Decided Jun 16, 2025 · 122 days after receipt
Device type: System, Nuclear Magnetic Resonance Imaging (LNH) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.